Cancer Metabolomics

2299-1085

Therapeutic Area

Biology, Biotechnology, Cytology/Cell Biology, General Medicine, Genomics, Internal Medicine, Molecular Medicine, Oncology

Biologists, Biomedical Researchers, Cell Biologists, Clinical Pharmacologists, Clinicians, Cytologists, Health Scientists, Medicinal Chemists, Molecular Biologists, Nurse Oncologists, Oncologists, Radiation Oncologists, Researchers, Scientists

The journal Cancer Metabolomics is devoted to the publication of research results in basic, translational and clinical studies for elucidation of metabolic biomarkers using NMR- and MS-based metabolomics. The primary mission of the journal is to become the central publication venue for all members of the researcher community in the area of metabolic markers for cancer detection and treatment using modern technology platforms. The journal is peer-reviewed, publishes in electronic-only format and on ongoing basis (no issues). Cancer Metabolomics publishes original research and review articles in the area of cancer metabolism, metabolic biomarkers and metabolomics technology advances. The major focus is translational science in the area of NMR- and MS-based metabolomics in oncology. Specific areas of interest include (but are not limited) to metabolic pathways of oncogenesis, metabolic biomarkers for early detection, staging and treatment response, technological advances in NMR and MS metabolomics, novel applications in bioinformatics and biostatistics, translational studies on metabolic biomarkers, and metabolic imaging.

No associations affiliated with this journal

Versita Ltd

Submission to Acceptance Acceptance to Online Publication Frequency Journal Contact Author Submission Guidelines